1. A tetravalent peptide efficiently inhibits the intestinal toxicity of heat-labile enterotoxin by targeting the receptor-binding region of the B-subunit pentamer.
- Author
-
Watanabe-Takahashi M, Tanigawa T, Hamabata T, and Nishikawa K
- Subjects
- Animals, Mice, Enterotoxigenic Escherichia coli drug effects, Enterotoxigenic Escherichia coli metabolism, Escherichia coli Proteins metabolism, Humans, Protein Binding, Binding Sites, Escherichia coli Infections drug therapy, Escherichia coli Infections metabolism, Amino Acid Sequence, Protein Subunits metabolism, Protein Subunits chemistry, Enterotoxins metabolism, Enterotoxins toxicity, Enterotoxins chemistry, Bacterial Toxins metabolism, Bacterial Toxins toxicity, Bacterial Toxins chemistry, Peptides pharmacology, Peptides chemistry, Peptides metabolism
- Abstract
Infection by enterotoxigenic Escherichia coli (ETEC) causes severe watery diarrhea and dehydration in humans. Heat-labile enterotoxin (LT) is a major virulence factor produced by ETEC. LT is one of AB
5 -type toxins, such as Shiga toxin (Stx) and cholera toxin (Ctx), and the B-subunit pentamer is responsible for high affinity binding to the LT-receptor, ganglioside GM1, through multivalent interaction. In this report, we found that Glu51 of the B-subunit plays an essential role in receptor binding compared with other amino acids, such as Glu11, Arg13, and Lys91, all of which were previously shown to be involved in the binding. By targeting Glu51, we identified four tetravalent peptides that specifically bind to the B-subunit pentamer with high affinity by screening tetravalent random-peptide libraries, which were tailored to bind to the B-subunit through multivalent interaction. One of these peptides, GGR-tet, efficiently inhibited the cell-elongation phenotype and the elevation of cellular cAMP levels, both induced by LT. Furthermore, GGR-tet markedly inhibited LT-induced fluid accumulation in the mouse ileum. Thus, GGR-tet represents a novel therapeutic agent against ETEC infection., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF